Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Pierre H. Deprez; Leon M.G. Moons; Dermot OʼToole; Rodica Gincul; Andrada Seicean; Pedro Pimentel-Nunes; Gloria Fernández-Esparrach; Marcin Polkowski; Michael Vieth; Ivan Borbath; Tom G. Moreels; Els Nieveen van Dijkum; Jean-Yves Blay; Jeanin E. van Hooft

doi:10.1055/a-1751-5742

Endoscopy, Inhaltsverzeichnis

Endoscopy 2022; 54(04): 412-429
DOI: 10.1055/a-1751-5742

Guideline

Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Pierre H. Deprez

¹Department of Hepatogastroenterology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium

,

Leon M.G. Moons

²Divisie Interne Geneeskunde en Dermatologie, Maag-, Darm- en Leverziekten, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands

,

Dermot OʼToole

³Neuroendocrine Tumor Service, ENETS Centre of Excellence, St. Vincent’s University Hospital and Department of Clinical Medicine, Trinity College Dublin, University of Dublin St. James’s Hospital, Dublin, Ireland

,

Rodica Gincul

⁴Service de Gastroentérologie et Endoscopie Digestive, Hôpital Privé Jean Mermoz, Lyon, France

,

Andrada Seicean

⁵Regional Institute of Gastroenterology and Hepatology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania

,

Pedro Pimentel-Nunes

⁶Department of Gastroenterology, Portuguese Oncology Institute of Porto; Department of Surgery and Physiology, Center for Research in Health Technologies and Information Systems (CINTESIS), Faculty of Medicine, University of Porto, Portugal

,

Gloria Fernández-Esparrach

⁷Endoscopy Unit, Institut de Malalties Digestives i Metaboliques, Hospital Clínic, Barcelona, Spain

,

Marcin Polkowski

⁸Department of Gastroenterology, Hepatology and Clinical Oncology, Center for Postgraduate Medical Education, and Department of Oncological Gastroenterology, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland

,

Michael Vieth

⁹Institut of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, Klinikum Bayreuth, Bayreuth, Germany

,

Ivan Borbath

¹Department of Hepatogastroenterology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium

,

Tom G. Moreels

¹Department of Hepatogastroenterology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium

,

Els Nieveen van Dijkum

¹⁰Department of Surgery, Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, The Netherlands

,

Jean-Yves Blay

¹¹Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon, France

,

Jeanin E. van Hooft

¹²Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands

› Institutsangaben

Abstract

Main Recommendations

1 ESGE recommends endoscopic ultrasonography (EUS) as the best tool to characterize subepithelial lesion (SEL) features (size, location, originating layer, echogenicity, shape), but EUS alone is not able to distinguish among all types of SEL.

Strong recommendation, moderate quality evidence.

2 ESGE suggests providing tissue diagnosis for all SELs with features suggestive of gastrointestinal stromal tumor (GIST) if they are of size > 20 mm, or have high risk stigmata, or require surgical resection or oncological treatment.

Weak recommendation, very low quality evidence.

3 ESGE recommends EUS-guided fine-needle biopsy (EUS-FNB) or mucosal incision-assisted biopsy (MIAB) equally for tissue diagnosis of SELs ≥ 20 mm in size.

Strong recommendation, moderate quality evidence.

4 ESGE recommends against surveillance of asymptomatic gastrointestinal (GI) tract leiomyomas, lipomas, heterotopic pancreas, granular cell tumors, schwannomas, and glomus tumors, if the diagnosis is clear.

Strong recommendation, moderate quality evidence.

5 ESGE suggests surveillance of asymptomatic esophageal and gastric SELs without definite diagnosis, with esophagogastroduodenoscopy (EGD) at 3–6 months, and then at 2–3-year intervals for lesions < 10 mm in size, and at 1–2-year intervals for lesions 10–20 mm in size. For asymptomatic SELs > 20 mm in size that are not resected, ESGE suggests surveillance with EGD plus EUS at 6 months and then at 6–12-month intervals.

Weak recommendation, very low quality evidence.

6 ESGE recommends endoscopic resection for type 1 gastric neuroendocrine neoplasms (g-NENs) if they grow larger than 10 mm. The choice of resection technique should depend on size, depth of invasion, and location in the stomach.

Strong recommendation, low quality evidence.

7 ESGE suggests considering removal of histologically proven gastric GISTs smaller than 20 mm as an alternative to surveillance. The decision to resect should be discussed in a multidisciplinary meeting. The choice of technique should depend on size, location, and local expertise.

Weak recommendation, very low quality evidence.

8 ESGE suggests that, to avoid unnecessary follow-up, endoscopic resection is an option for gastric SELs smaller than 20 mm and of unknown histology after failure of attempts to obtain diagnosis.

Weak recommendation, very low quality evidence.

9 ESGE recommends basing the surveillance strategy on the type and completeness of resection. After curative resection of benign SELs no follow-up is advised, except for type 1 gastric NEN for which surveillance at 1–2 years is advised.

Strong recommendation, low quality evidence.

10 For lower or upper GI NEN with a positive or indeterminate margin at resection, ESGE recommends repeating endoscopy at 3–6 months and another attempt at endoscopic resection in the case of residual disease.

Strong recommendation, low quality evidence.

Volltext

Referenzen

References
1 Atkins D, Eccles M, Flottorp S. et al. Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res 2004; 4: 38
2 Dumonceau J-M, Hassan C, Riphaus A. et al. European Society of Gastrointestinal Endoscopy (ESGE) Guideline Development Policy. Endoscopy 2012; 44: 626-629
3 Nishida T, Kawai N, Yamaguchi S. et al. Submucosal tumors: Comprehensive guide for the diagnosis and therapy of gastrointestinal submucosal tumors. Dig Endosc 2013; 25: 479-489
4 Menon L, Buscaglia JM. Endoscopic approach to subepithelial lesions. Ther Adv Gastroenterol 2014; 7: 123-130
5 Akahoshi K, Oya M, Koga T. et al. Current clinical management of gastrointestinal stromal tumor. World J Gastroenterol 2018; 24: 2806-2817
6 Agaimy A, Wünsch PH, Hofstaedter F. et al. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol 2007; 31: 113-120
7 Casali PG, Abecassis N, Aro HT. et al. Gastrointestinal stromal tumours: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 29: iv68-iv78
8 Corless CL, Barnett CM, Heinrich MC. Gastrointestinal stromal tumours: origin and molecular oncology. Nat Rev Cancer 2011; 11: 865-878
9 Boikos SA, Stratakis CA. The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA mutations. Endocrine 2014; 47: 401-408
10 Rossi S, Gasparotto D, Toffolatti L. et al. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. Am J Surg Pathol 2010; 34: 1480-1491
11 Dasari A, Shen C, Halperin D. et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 2017; 3: 1335-1342
12 Felder S, Jann H, Arsenic R. et al. Gastric neuroendocrine neoplasias: manifestations and comparative outcomes. Endocr Relat Cancer 2019; 26: 751-763
13 Rindi G. The ENETS guidelines: the new TNM classification system. Tumori 2010; 96: 806-809
14 Rösch T, Kapfer B, Will U. et al. Accuracy of endoscopic ultrasonography in upper gastrointestinal submucosal lesions: a prospective multicenter study. Scand J Gastroenterol 2002; 37: 856-862
15 Białek A, Wiechowska-Kozłowska A, Pertkiewicz J. et al. Endoscopic submucosal dissection for treatment of gastric subepithelial tumors (with video). Gastrointest Endosc 2012; 75: 276-286
16 He G, Wang J, Chen B. et al. Feasibility of endoscopic submucosal dissection for upper gastrointestinal submucosal tumors treatment and value of endoscopic ultrasonography in pre-operation assess and post-operation follow-up: a prospective study of 224 cases in a single medical center. Surg Endosc 2016; 30: 4206-4213
17 Chen H-T, Xu G-Q, Teng X-D. et al. Diagnostic accuracy of endoscopic ultrasonography for rectal neuroendocrine neoplasms. World J Gastroenterol 2014; 20: 10470-10477
18 Li Q-L, Zhang Y-Q, Chen W-F. et al. Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study. World J Gastroenterol 2012; 18: 5799-5806
19 Rösch T, Lorenz R, Dancygier H. et al. Endosonographic diagnosis of submucosal upper gastrointestinal tract tumors. Scand J Gastroenterol 1992; 27: 1-8
20 Kim SY, Shim K-N, Lee J-H. et al. Comparison of the diagnostic ability of endoscopic ultrasonography and abdominopelvic computed tomography in the diagnosis of gastric subepithelial tumors. Clin Endosc 2019; 52: 565-573
21 Karaca C, Turner BG, Cizginer S. et al. Accuracy of EUS in the evaluation of small gastric subepithelial lesions. Gastrointest Endosc 2010; 71: 722-727
22 Kim GH, Park DY, Kim S. et al. Is it possible to differentiate gastric GISTs from gastric leiomyomas by EUS?. World J Gastroenterol 2009; 15: 3376-3381
23 Khan S, Zhang R, Fang W. et al. Reliability of endoscopic ultrasound using miniprobes and grayscale histogram analysis in diagnosing upper gastrointestinal subepithelial lesions. Gastroenterol Res Pract 2020; 2020: 6591341
24 Minoda Y, Ihara E, Komori K. et al. Efficacy of endoscopic ultrasound with artificial intelligence for the diagnosis of gastrointestinal stromal tumors. J Gastroenterol 2020; 55: 1119-1126
25 Brand B, Oesterhelweg L, Binmoeller KF. et al. Impact of endoscopic ultrasound for evaluation of submucosal lesions in gastrointestinal tract. Dig Liver Dis 2002; 34: 290-297
26 Chen T-H, Hsu C-M, Chu Y-Y. et al. Association of endoscopic ultrasonographic parameters and gastrointestinal stromal tumors (GISTs): can endoscopic ultrasonography be used to screen gastric GISTs for potential malignancy?. Scand J Gastroenterol 2016; 51: 374-377
27 Ra JC, Lee ES, Lee JB. et al. Diagnostic performance of stomach CT compared with endoscopic ultrasonography in diagnosing gastric subepithelial tumors. Abdom Radiol N Y 2017; 42: 442-450
28 Okten RS, Kacar S, Kucukay F. et al. Gastric subepithelial masses: evaluation of multidetector CT (multiplanar reconstruction and virtual gastroscopy) versus endoscopic ultrasonography. Abdom Imaging 2012; 37: 519-530
29 Tang JY, Tao KG, Zhang LY. et al. Value of contrast-enhanced harmonic endoscopic ultrasonography in differentiating between gastrointestinal stromal tumors: A meta-analysis. J Dig Dis 2019; 20: 127-134
30 Sakamoto H, Kitano M, Matsui S. et al. Estimation of malignant potential of GI stromal tumors by contrast-enhanced harmonic EUS (with videos). Gastrointest Endosc 2011; 73: 227-237
31 Zhao Y, Qian L, Li P. et al. The diagnostic value of endoscopic ultrasonography and contrast-enhanced harmonic endoscopic ultrasonography in gastrointestinal stromal tumors. Endosc Ultrasound 2016; 5: 111-117
32 Tsuji Y, Kusano C, Gotoda T. et al. Diagnostic potential of endoscopic ultrasonography-elastography for gastric submucosal tumors: A pilot study. Dig Endosc 2016; 28: 173-178
33 Kannengiesser K, Mahlke R, Petersen F. et al. Contrast-enhanced harmonic endoscopic ultrasound is able to discriminate benign submucosal lesions from gastrointestinal stromal tumors. Scand J Gastroenterol 2012; 47: 1515-1520
34 Yamashita Y, Kato J, Ueda K. et al. Contrast-enhanced endoscopic ultrasonography can predict a higher malignant potential of gastrointestinal stromal tumors by visualizing large newly formed vessels. J Clin Ultrasound JCU 2015; 43: 89-97
35 Pesenti C, Bories E, Caillol F. et al. Characterization of subepithelial lesions of the stomach and esophagus by contrast-enhanced EUS: A retrospective study. Endosc Ultrasound 2019; 8: 43-49
36 Kamata K, Takenaka M, Kitano M. et al. Contrast-enhanced harmonic endoscopic ultrasonography for differential diagnosis of submucosal tumors of the upper gastrointestinal tract. J Gastroenterol Hepatol 2017; 32: 1686-1692
37 Ignee A, Jenssen C, Hocke M. et al. Contrast-enhanced (endoscopic) ultrasound and endoscopic ultrasound elastography in gastrointestinal stromal tumors. Endosc Ultrasound 2017; 6: 55-60
38 Kim SH, Yoo IK, Kwon C-I. et al. Utility of EUS elastography in the diagnosis of gastric subepithelial tumors: a pilot study (with video). Gastrointest Endosc 2020; 91: 172-177.e2
39 Park HY, Jeon SW, Lee HS. et al. Can contrast-enhanced harmonic endosonography predict malignancy risk in gastrointestinal subepithelial tumors?. Endosc Ultrasound 2016; 5: 384-389
40 Lee HS, Cho CM, Kwon YH. et al. Predicting malignancy risk in gastrointestinal subepithelial tumors with contrast-enhanced harmonic endoscopic ultrasonography using perfusion analysis software. Gut Liver 2019; 13: 161-168
41 Akahoshi K, Oya M, Koga T. et al. Clinical usefulness of endoscopic ultrasound-guided fine needle aspiration for gastric subepithelial lesions smaller than 2 cm. J Gastrointestin Liver Dis 2014; 23: 405-412
42 ESMO/European Sarcoma Network Working Group. Gastrointestinal stromal tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014; 25 (Suppl. 03) iii21-26
43 Nishida T, Hirota S, Yanagisawa A. et al. Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version. Int J Clin Oncol 2008; 13: 416-430
44 Li J, Ye Y, Wang J. et al. Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor. Chin J Cancer Res Chung-Kuo Yen Cheng Yen Chiu 2017; 29: 281-293
45 von Mehren M, Kane JM, Bui MM. et al. NCCN guidelines insights: Soft tissue sarcoma, version 1.2021. J Natl Compr Canc Netw 2020; 18: 1604-1612
46 Dumonceau J-M, Deprez PH, Jenssen C. et al. Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline – Updated January 2017. Endoscopy 2017; 49: 695-714
47 Cho JW, Korean ESD Study Group. Current guidelines in the management of upper gastrointestinal subepithelial tumors. Clin Endosc 2016; 49: 235-240
48 Sanaei O, Fernández-Esparrach G, De La Serna-Higuera C. et al. EUS-guided 22-gauge fine needle biopsy versus single-incision with needle knife for the diagnosis of upper gastrointestinal subepithelial lesions: a randomized controlled trial. Endosc Int Open 2020; 8: E266-E273
49 Osoegawa T, Minoda Y, Ihara E. et al. Mucosal incision-assisted biopsy versus endoscopic ultrasound-guided fine-needle aspiration with a rapid on-site evaluation for gastric subepithelial lesions: A randomized cross-over study. Dig Endosc 2019; 31: 413-421
50 Dhaliwal A, Kolli S, Dhindsa BS. et al. Clinical efficacy and safety of mucosal incision-assisted biopsy for the diagnosis of upper gastrointestinal subepithelial tumors: A systematic review and meta-analysis. Ann Gastroenterol 2020; 33: 155-161
51 Dhaliwal A, Kolli S, Dhindsa BS. et al. Diagnostic yield of deep biopsy via endoscopic submucosal dissection for the diagnosis of upper gastrointestinal subepithelial tumors: a systematic review and meta-analysis. Ann Gastroenterol 2020; 33: 30-37
52 Zoundjiekpon V, Falt P, Fojtik P. et al. Endosonography-guided fine-needle aspiration versus “key-hole biopsy“ in the diagnostics of upper gastrointestinal subepithelial tumors. A prospective randomized interventional study. Biomed Pap Med Fac Univ Palacky Olomouc Czechoslov 2020; 164: 63-70
53 Minoda Y, Chinen T, Osoegawa T. et al. Superiority of mucosal incision-assisted biopsy over ultrasound-guided fine needle aspiration biopsy in diagnosing small gastric subepithelial lesions: a propensity score matching analysis. BMC Gastroenterol 2020; 20: 19
54 Zhang X-C, Li Q-L, Yu Y-F. et al. Diagnostic efficacy of endoscopic ultrasound-guided needle sampling for upper gastrointestinal subepithelial lesions: a meta-analysis. Surg Endosc 2016; 30: 2431-2441
55 Facciorusso A, Sunny SP, Del Prete V. et al. Comparison between fine-needle biopsy and fine-needle aspiration for EUS-guided sampling of subepithelial lesions: a meta-analysis. Gastrointest Endosc 2020; 91: 14-22.e2
56 Nishida T, Hølmebakk T, Raut CP. et al. Defining tumor rupture in gastrointestinal stromal tumor. Ann Surg Oncol 2019; 26: 1669-1675
57 Trindade AJ, Benias PC, Alshelleh M. et al. Fine-needle biopsy is superior to fine-needle aspiration of suspected gastrointestinal stromal tumors: a large multicenter study. Endosc Int Open 2019; 7: E931-E936
58 de Moura DTH, McCarty TR, Jirapinyo P. et al. EUS-guided fine-needle biopsy sampling versus FNA in the diagnosis of subepithelial lesions: a large multicenter study. Gastrointest Endosc 2020; 92: 108-119.e3
59 Hedenström P, Marschall H-U, Nilsson B. et al. High clinical impact and diagnostic accuracy of EUS-guided biopsy sampling of subepithelial lesions: a prospective, comparative study. Surg Endosc 2018; 32: 1304-1313
60 Okuwaki K, Masutani H, Kida M. et al. Diagnostic efficacy of white core cutoff lengths obtained by EUS-guided fine-needle biopsy using a novel 22G franseen biopsy needle and sample isolation processing by stereomicroscopy for subepithelial lesions. Endosc Ultrasound 2020; 9: 187-192
61 Kim GH, Ahn JY, Gong CS. et al. Efficacy of endoscopic ultrasound-guided fine-needle biopsy in gastric subepithelial tumors located in the cardia. Dig Dis Sci 2020; 65: 583-590
62 Kim GH, Cho YK, Kim EY. et al. Comparison of 22-gauge aspiration needle with 22-gauge biopsy needle in endoscopic ultrasonography-guided subepithelial tumor sampling. Scand J Gastroenterol 2014; 49: 347-354
63 Gilani SM, Muniraj T, Aslanian HR. et al. Endoscopic ultrasound-guided fine needle aspiration cytology diagnosis of upper gastrointestinal tract mesenchymal tumors: Impact of rapid onsite evaluation and correlation with histopathologic follow-up. Diagn Cytopathol 2021; 49: 203-210
64 Kim J, Kim JY, Oh EH. et al. Chromogranin A expression in rectal neuroendocrine tumors is associated with more aggressive clinical behavior and a poorer prognosis. Am J Surg Pathol 2020; 44: 1496-1505
65 Zhang H, Liu Q. Prognostic indicators for gastrointestinal stromal tumors: A review. Transl Oncol 2020; 13: 100812
66 Larghi A, Fuccio L, Chiarello G. et al. Fine-needle tissue acquisition from subepithelial lesions using a forward-viewing linear echoendoscope. Endoscopy 2014; 46: 39-45
67 Polkowski M, Gerke W, Jarosz D. et al. Diagnostic yield and safety of endoscopic ultrasound-guided trucut corrected biopsy in patients with gastric submucosal tumors: a prospective study. Endoscopy 2009; 41: 329-334
68 Kataoka M, Kawai T, Ikemiyagi H. et al. Clinicopathological characteristic and clinical handling of the patients with 2 cm or less gastric GISTs. SpringerPlus 2013; 2: 469
69 Ricci R, Chiarello G, Attili F. et al. Endoscopic ultrasound-guided fine needle tissue acquisition biopsy samples do not allow a reliable proliferation assessment of gastrointestinal stromal tumours. Dig Liver Dis 2015; 47: 291-295
70 Ando N, Goto H, Niwa Y. et al. The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. Gastrointest Endosc 2002; 55: 37-43
71 Seven G, Kochan K, Caglar E. et al. Evaluation of Ki67 index in endoscopic ultrasound-guided fine needle aspiration samples for the assessment of malignancy risk in gastric gastrointestinal stromal tumors. Dig Dis Basel Switz 2021; 39: 407-414
72 Oberg K, Couvelard A, Delle Fave G. et al. ENETS consensus guidelines for standard of care in neuroendocrine tumours: Biochemical markers. Neuroendocrinology 2017; 105: 201-211
73 O’Toole D, Grossman A, Gross D. et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Biochemical markers. Neuroendocrinology 2009; 90: 194-202
74 Ramage JK, De Herder WW, Delle Fave G. et al. ENETS consensus guidelines update for colorectal neuroendocrine neoplasms. Neuroendocrinology 2016; 103: 139-143
75 Delle Fave G, Kwekkeboom DJ, Van Cutsem E. et al. ENETS consensus guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology 2012; 95: 74-87
76 Landi B, Blay J-Y, Bonvalot S. et al. Gastrointestinal stromal tumours (GISTs): French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Dig Liver Dis 2019; 51: 1223-1231
77 Song JH, Kim SG, Chung SJ. et al. Risk of progression for incidental small subepithelial tumors in the upper gastrointestinal tract. Endoscopy 2015; 47: 675-679
78 Kushnir VM, Keswani RN, Hollander TG. et al. Compliance with surveillance recommendations for foregut subepithelial tumors is poor: results of a prospective multicenter study. Gastrointest Endosc 2015; 81: 1378-1384
79 Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T. et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 829-854
80 Kumar S, Chandrasekhara V, Kochman ML. et al. Ligation-assisted endoscopic mucosal resection for esophageal granular cell tumors is safe and effective. Dis Esophagus 2020; 33: doaa027
81 Lu W, Xu M-D, Zhou P-H. et al. Endoscopic submucosal dissection of esophageal granular cell tumor. World J Surg Oncol 2014; 12: 221
82 Ye L-P, Zhang Y, Mao X-L. et al. Submucosal tunnelling endoscopic resection for the treatment of esophageal submucosal tumours originating from the muscularis propria layer: an analysis of 15 cases. Dig Liver Dis 2013; 45: 119-123
83 Zhang Y, Peng J-B, Mao X-L. et al. Endoscopic resection of large (≥ 4 cm) upper gastrointestinal subepithelial tumors originating from the muscularis propria layer: a single-center study of 101 cases (with video). Surg Endosc 2021; 35: 1442-1452
84 Peng W, Tan S, Huang S. et al. Efficacy and safety of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors with more than 1-year follow-up: a systematic review and meta-analysis. Scand J Gastroenterol 2019; 54: 397-406
85 Lv X-H, Wang C-H, Xie Y. Efficacy and safety of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors: a systematic review and meta-analysis. Surg Endosc 2017; 31: 49-63
86 Grozinsky-Glasberg S, Thomas D, Strosberg JR. et al. Metastatic type 1 gastric carcinoid: a real threat or just a myth?. World J Gastroenterol 2013; 19: 8687-8695
87 Tsolakis AV, Ragkousi A, Vujasinovic M. et al. Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis. World J Gastroenterol 2019; 25: 5376-5387
88 Chen WF, Zhou PH, Li QL. et al. Clinical impact of endoscopic submucosal dissection for gastric neuroendocrine tumors: a retrospective study from mainland China. ScientificWorldJournal 2012;
89 Kim HH, Kim GH, Kim JH. et al. The efficacy of endoscopic submucosal dissection of type I gastric carcinoid tumors compared with conventional endoscopic mucosal resection. Gastroenterol Res Pract 2014; 2014: 253860
90 Jung HJ, Hong SJ, Han JP. et al. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors. J Dig Dis 2015; 16: 595-600
91 Exarchou K, Howes N, Pritchard DM. Systematic review: management of localised low-grade upper gastrointestinal neuroendocrine tumours. Aliment Pharmacol Ther 2020; 51: 1247-1267
92 Min B-H, Hong M, Lee JH. et al. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours. Br J Surg 2018; 105: 1480-1486
93 Li Y-L, Qiu X-D, Chen J. et al. Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours. World J Gastrointest Oncol 2020; 12: 1416-1427
94 Hirasawa T, Yamamoto N, Sano T. Is endoscopic resection appropriate for type 3 gastric neuroendocrine tumors? Retrospective multicenter study.. Dig Endosc 2021; 33: 408-417
95 Ingason AB, Theodors A, Agustsson AS. et al. Giant gastric lipoma successfully removed by endoscopic submucosal dissection: case report and systematic review. Scand J Gastroenterol 2018; 53: 1018-1024
96 Wang C, Gao Z, Shen K. et al. Safety and efficiency of endoscopic resection versus laparoscopic resection in gastric gastrointestinal stromal tumours: A systematic review and meta-analysis. Eur J Surg Oncol 2020; 46: 667-674
97 Zhang Q, Gao L-Q, Han Z-L. et al. Effectiveness and safety of endoscopic resection for gastric GISTs: a systematic review. Minim Invasive Ther Allied Technol 2018; 27: 127-137
98 Cao B, Lu J, Tan Y. et al. Efficacy and safety of submucosal tunneling endoscopic resection for gastric submucosal tumors: a systematic review and meta-analysis. Rev Espanola Enfermedades Dig 2021; 113: 52-59
99 Antonino G, Alberto M, Michele A. et al. Efficacy and safety of gastric exposed endoscopic full-thickness resection without laparoscopic assistance: a systematic review. Endosc Int Open 2020; 8: E1173-E1182
100 Meier B, Schmidt A, Glaser N. et al. Endoscopic full-thickness resection of gastric subepithelial tumors with the gFTRD-system: a prospective pilot study (RESET trial). Surg Endosc 2020; 34: 853-860
101 Hajifathalian K, Ichkhanian Y, Dawod Q. et al. Full-thickness resection device (FTRD) for treatment of upper gastrointestinal tract lesions: the first international experience. Endosc Int Open 2020; 8: E1291-E1301
102 Kappelle WFW, Backes Y, Valk GD. et al. Endoscopic full-thickness resection of gastric and duodenal subepithelial lesions using a new, flat-based over-the-scope clip. Surg Endosc 2018; 32: 2839-2846
103 Jin X-F, Gai W, Du R-L. et al. Multiband mucosectomy versus endoscopic submucosal dissection and endoscopic submucosal excavation for GI submucosal tumors: short and long term follow-up. BMC Cancer 2019; 19: 893
104 Zhang J-S, Ye L-P, Wang C-Y. et al. Endoscopic submucosal enucleation of small gastric gastrointestinal stromal tumors with cross-shaped incision: report of sixty-nine cases. Hepatogastroenterology 2012; 59: 440-443
105 Xiu H, Zhao C-Y, Liu F-G. et al. Comparing about three types of endoscopic therapy methods for upper gastrointestinal submucosal tumors originating from the muscularis propria layer. Scand J Gastroenterol 2019; 54: 1481-1486
106 Chen Y, Wang M, Zhao L. et al. The retrospective comparison between submucosal tunneling endoscopic resection and endoscopic submucosal excavation for managing esophageal submucosal tumors originating from the muscularis propria layer. Surg Endosc 2020; 34: 417-428
107 Xu H-W, Zhao Q, Yu S-X. et al. Comparison of different endoscopic resection techniques for submucosal tumors originating from muscularis propria at the esophagogastric junction. BMC Gastroenterol 2019; 19: 174
108 Zhu Y, Xu M-D, Xu C. et al. Microscopic positive tumor margin does not increase the rate of recurrence in endoscopic resected gastric mesenchymal tumors compared to negative tumor margin. Surg Endosc 2020; 34: 159-169
109 Zhai Y-Q, Chai N-L, Li H-K. et al. Endoscopic submucosal excavation and endoscopic full-thickness resection for gastric schwannoma: five-year experience from a large tertiary center in China. Surg Endosc 2020; 34: 4943-4949
110 Lee SW, Sung JK, Cho YS. et al. Comparisons of therapeutic outcomes in patients with nonampullary duodenal neuroendocrine tumors (NADNETs): A multicenter retrospective study. Medicine (Baltimore) 2019; 98: e16154
111 Vanoli A, La Rosa S, Klersy C. et al. Four neuroendocrine tumor types and neuroendocrine carcinoma of the duodenum: Analysis of 203 cases. Neuroendocrinology 2017; 104: 112-125
112 Gincul R, Ponchon T, Napoleon B. et al. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors. Endoscopy 2016; 48: 979-986
113 Kim GH, Kim JI, Jeon SW. et al. Endoscopic resection for duodenal carcinoid tumors: a multicenter, retrospective study. J Gastroenterol Hepatol 2014; 29: 318-324
114 Hatta W, Koike T, Iijima K. et al. The risk factors for metastasis in non-ampullary duodenal neuroendocrine tumors measuring 20 mm or less in diameter. Digestion 2017; 95: 201-209
115 Dasari BVM, Al-Shakhshir S, Pawlik TM. et al. Outcomes of surgical and endoscopic resection of duodenal neuroendocrine tumours (NETs): A systematic review of the literature. J Gastrointest Surg 2018; 22: 1652-1658
116 Oono Y, Shinmura K, Hori K. et al. Endoscopic submucosal resection using a ligation device without injection for duodenal neuroendocrine tumors. Surg Endosc 2019; 33: 2008-2014
117 Nishio M, Hirasawa K, Ozeki Y. et al. Short- and long-term outcomes of endoscopic submucosal dissection for non-ampullary duodenal neuroendocrine tumors. Ann Gastroenterol 2020; 33: 265-271
118 Klemm N, Lu-Cleary D, Chahal D. et al. Endoscopic management of diminutive duodenal neuroendocrine tumors. J Gastrointest Cancer 2020; 52: 448-453
119 Bauder M, Schmidt A, Caca K. Endoscopic full-thickness resection of duodenal lesions-a retrospective analysis of 20 FTRD cases. United Eur Gastroenterol J 2018; 6: 1015-1021
120 Khara HS, Shovlin GJ, Johal AS. et al. Endoscopic banding without resection (BWR) technique for treatment of diminutive neuroendocrine tumors in the duodenum. Endosc Int Open 2019; 7: E302-E307
121 Exarchou K, Moore AR, Smart HL. et al. A “watch and wait“ strategy involving regular endoscopic surveillance is safe for many patients with small, sporadic, grade 1, non-ampullary, non-functioning duodenal neuroendocrine tumours. Neuroendocrinology 2020;
122 Ren Z, Lin S-L, Zhou P-H. et al. Endoscopic full-thickness resection (EFTR) without laparoscopic assistance for nonampullary duodenal subepithelial lesions: our clinical experience of 32 cases. Surg Endosc 2019; 33: 3605-3611
123 de Mestier L, Lorenzo D, Fine C. et al. Endoscopic, transanal, laparoscopic, and transabdominal management of rectal neuroendocrine tumors. Best Pract Res Clin Endocrinol Metab 2019; 33: 101293
124 Zhou X, Xie H, Xie L. et al. Factors associated with lymph node metastasis in radically resected rectal carcinoids: a systematic review and meta-analysis. J Gastrointest Surg 2013; 17: 1689-1697
125 Kuiper T, van Oijen MGH, van Velthuysen MF. et al. Endoscopically removed rectal NETs: a nationwide cohort study. Int J Colorectal Dis 2021; 36: 535-541
126 Chen T, Yao L-Q, Xu M-D. et al. Efficacy and safety of endoscopic submucosal dissection for colorectal carcinoids. Clin Gastroenterol Hepatol 2016; 14: 575-581
127 Bang BW, Park JS, Kim HK. et al. Endoscopic resection for small rectal neuroendocrine tumors: comparison of endoscopic submucosal resection with band ligation and endoscopic submucosal dissection. Gastroenterol Res Pract 2016; 2016: 6198927
128 Zhang H-P, Wu W, Yang S. et al. Endoscopic treatments for rectal neuroendocrine tumors smaller than 16 mm: a meta-analysis. Scand J Gastroenterol 2016; 51: 1345-1353
129 Pan J, Zhang X, Shi Y. et al. Endoscopic mucosal resection with suction vs. endoscopic submucosal dissection for small rectal neuroendocrine tumors: a meta-analysis. Scand J Gastroenterol 2018; 53: 1139-1145
130 Zheng J-C, Zheng K, Zhao S. et al. Efficacy and safety of modified endoscopic mucosal resection for rectal neuroendocrine tumors: a meta-analysis. Z Gastroenterol 2020; 58: 137-145
131 Ramage JK, Valle JW, Nieveen van Dijkum EJM. et al. Colorectal neuroendocrine neoplasms: areas of unmet need. Neuroendocrinology 2019; 108: 45-53
132 Stier MW, Chapman CG, Shamah S. et al. Endoscopic resection is more effective than biopsy or EUS to detect residual rectal neuroendocrine tumor. Endosc Int Open 2021; 9: E4-E8
133 Xu M, Wang X-Y, Zhou P-H. et al. Endoscopic full-thickness resection of colonic submucosal tumors originating from the muscularis propria: an evolving therapeutic strategy. Endoscopy 2013; 45: 770-773
134 Yoon YS, Cho YB, Park KJ. et al. Surgical outcomes of Korean ulcerative colitis patients with and without colitis-associated cancer. World J Gastroenterol 2015; 21: 3547-3553
135 Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006; 23: 70-83
136 Zwager LW, Bastiaansen BAJ, Bronzwaer MES. et al. Endoscopic full-thickness resection (eFTR) of colorectal lesions: results from the Dutch colorectal eFTR registry. Endoscopy 2020; 52: 1014-1023
137 Clark OH, Benson AB, Berlin JD. et al. NCCN Clinical practice guidelines in oncology: Neuroendocrine tumors. J Natl Compr Cancer Netw JNCCN 2009; 7: 712-747
138 Scherübl H, Cadiot G. Early gastroenteropancreatic neuroendocrine tumors: Endoscopic therapy and surveillance. Visc Med 2017; 33: 332-338

Zusatzmaterial

Zusatzmaterial